Marquette General Cancer Center
Head and Neck
Study Name - ECOG E1305
Study
Description - A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer.
IRB Open Date - 03/04/2011
Data Privacy Statement for Research Studies
|
|
|||